One week ago Express Scripts (NASDAQ:ESRX) was downgraded from Outperform to Neutral at Macquarie. Express Scripts shares are selling at $55.12, 3.3% below the $56.98 price point of one week ago.
Express Scripts share prices have moved between a 52-week high of $66.06 and a 52-week low of $34.47 and are now trading 59% above that low price at $54.71 per share. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has remained constant.
Express Scripts, Inc is a full service pharmacy benefit management and specialty managed care company serving clients throughout North America. The Company's customers include managed care organizations, insurance carriers, third party administrators, employers, and union-sponsored benefit plans. Express provides pharmacy network management, formulary management, and other services.
Express Scripts (NASDAQ:ESRX) has potential upside of 16.4% based on a current price of $54.71 and analysts' consensus price target of $63.68. The stock should run into initial resistance at its 50-day moving average (MA) of $54.73 and subsequent resistance at its 200-day MA of $56.82.